Your browser doesn't support javascript.
loading
EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer.
Gong, Ke; Guo, Gao; Panchani, Nishah; Bender, Matthew E; Gerber, David E; Minna, John D; Fattah, Farjana; Gao, Boning; Peyton, Michael; Kernstine, Kemp; Mukherjee, Bipasha; Burma, Sandeep; Chiang, Cheng-Ming; Zhang, Shanrong; Amod Sathe, Adwait; Xing, Chao; Dao, Kathryn H; Zhao, Dawen; Akbay, Esra A; Habib, Amyn A.
Afiliación
  • Gong K; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Guo G; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Panchani N; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Bender ME; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Gerber DE; Department of Internal Medicine, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Minna JD; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Fattah F; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Gao B; Department of Internal Medicine, Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Peyton M; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Kernstine K; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Mukherjee B; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Burma S; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Chiang CM; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Zhang S; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Amod Sathe A; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Xing C; Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Dao KH; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Zhao D; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Akbay EA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Habib AA; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Nat Cancer ; 1(4): 394-409, 2020 04.
Article en En | MEDLINE | ID: mdl-33269343
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transducción de Señal / Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido